CONSOLIDATED STATEMENTS STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020			0	24,812,487
Beginning balance at Dec. 31, 2020	$ 415,691	$ 21	$ 0	$ 25	$ 478,162	$ (62,496)	$ 21
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 21,740				21,740
Exercise of common stock options (in shares)	414,890			416,037
Exercise of common stock options	$ 4,234				4,234
Issuance of common stock from vested restricted stock units and payment of employees’ taxes (in shares)				39,548
Issuance of common stock from vested restricted stock units and payment of employees’ taxes	(781)				(781)
Public offerings of common stock, adjustment to offering costs	39				39
Issuance of common stock under the employee stock purchase plan (in shares)				110,448
Issuance of common stock under the employee stock purchase plan	2,088				2,088
Net unrealized loss on available-for-sale securities	0
Net loss	(31,292)					(31,292)
Ending balance (in shares) at Dec. 31, 2021			0	25,378,520
Ending balance at Dec. 31, 2021	$ 411,740		$ 0	$ 25	505,482	(93,767)		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-02
Stock-based compensation expense	$ 36,321				36,321
Exercise of common stock options (in shares)	148,735			148,735
Exercise of common stock options	$ 833			$ 1	832
Issuance of common stock from vested restricted stock units and payment of employees’ taxes (in shares)				183,887
Issuance of common stock from vested restricted stock units and payment of employees’ taxes	(1,688)				(1,688)
Issuance of common stock under the employee stock purchase plan (in shares)				78,652
Issuance of common stock under the employee stock purchase plan	2,352				2,352
Issuance of common stock in acquisition of business (in shares)				763,887
Issuance of common stock in acquisition of business	17,111			$ 1	17,110
Net unrealized loss on available-for-sale securities	(381)							(381)
Net loss	(67,138)					(67,138)
Ending balance (in shares) at Dec. 31, 2022			0	26,553,681
Ending balance at Dec. 31, 2022	$ 399,150		$ 0	$ 27	$ 560,409	$ (160,905)		$ (381)